John M Leonard insider trades

Open-market stock purchases and sales by John M Leonard, President and CEO at Intellia Therapeutics, Inc, from SEC Form 4 filings since Oct 7, 2020.

Recent trades

DateStockTradeValue
Aug 21, 2026NTLA Intellia Therapeutics, IncSold$36.2K
Aug 20, 2026NTLA Intellia Therapeutics, IncSold$251K
Apr 23, 2026IQV Iqvia Holdings IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$314K
Dec 12, 2025NTLA Intellia Therapeutics, IncBought (not open market)—
Dec 11, 2025NTLA Intellia Therapeutics, IncSold$474K
Dec 11, 2025NTLA Intellia Therapeutics, IncSold$311K
Dec 11, 2025NTLA Intellia Therapeutics, IncSold$51.4K
Dec 11, 2025NTLA Intellia Therapeutics, IncBought (not open market)—

Companies traded

  • NTLA Intellia Therapeutics, Inc: 54 sales, last Aug 21, 2026
  • IQV Iqvia Holdings Inc: other filings, last Apr 23, 2026

Get free alerts when John M Leonard files a new trade →